skip to primary navigationskip to content
 

Taking parked therapies into overdrive

last modified Apr 28, 2014 04:09 PM
Healx3 is aiming to breathe new life into parked therapeutics and dormant IP in the biopharmaceutical industry.

 

The start-up, based at ideaSpace West, hopes to take the medical technology parked by biopharmaceutical companies and turn it into new drugs and therapies. Healx3 is currently in talks with biopharma companies on potential partnerships.

In an interview with Business Weekly, CEO Tim Guilliams, who holds a PhD in molecular neuroscience from the University of Cambridge, says: “Around 90 per cent of drug development projects never make it to market – leaving a vast amount of parked bio-assets on company benches.

“Some of these assets still have therapeutic potential, but do not cure patients or generate revenue. Healx3 is specialising in the upcycle and out-licensing of parked therapeutics and dormant IP in the biopharmaceutical industry.

“By enabling companies to generate new revenue streams and promote collaborative innovation within the industry, our activities will help deliver the next generation of therapeutics to patients in need.”

Healx3 is currently self-funded but aims to seek angel support once it has created strategic partnerships, launching a pilot with around 10 assets and pushing for seed capital around September.

To read the full article visit here

For more on Healx3 see http://www.healx3.com/

RSS Feed Latest news

A Conversation with Europe’s Leading Entrepreneurs and Investors at Queens' College

Mar 23, 2017

Top UK Founders provide inspiration to the next generation

Owlstone Medical Opens New Breath Biopsy Lab

Mar 20, 2017

Tony Blair officially opened the new high volume lab in Cambridge last week

Sound the Siren! Data Intelligence Company backed by Top VCs

Mar 06, 2017

Siren Solutions have won €1M of seed round funding from Ireland’s Top VCs

Spectral Edge Deliver the Perfect Picture

Feb 23, 2017

Spectral Edge launches Phusion video personalisation for Android devices

Progressive Developments for Cancer Diagnosis

Jan 12, 2017

Funding to support Owlstone Medical’s breath-taking medical advancements

View all news